The role of biological sciences in understanding the genesis and a new therapeutic approach to Alzheimer’s disease
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2011, Vol 65, Issue 0
Abstract
The paper contrasts the historical view on causal factors in Alzheimer’s disease (AD) with the modern concept of the symptoms’ origin. Biological sciences dealing with cell structure and physiology enabled comprehension of the role of mitochondrial defects in the processes of formation of neurofibrillary tangles and β-amyloid, which in turn gives hope for developing a new, more effective therapeutic strategy for AD. It has been established that although mitochondria constantly generate free radicals, from which they are protected by their own defensive systems, in some situations these systems become deregulated, which leads to free radical-based mitochondrial defects. This causes an energetic deficit in neurons and a further increase in the free radical pool. As a result, due to compensation processes, formation of tangles and/or acceleration of β-amyloid production takes place. The nature of these processes is initially a protective one, due to their anti-oxidative action, but as the amount of the formations increases, their beneficial effect wanes. They become a storage place for substances enhancing free radical processes, which makes them toxic themselves. It is such an approach to the primary causal factor for AD which lies at the roots of the new view on AD therapy, suggesting the use of methylene blue-based drugs, laser or intranasally applied insulin. A necessary condition, however, for these methods’ effectiveness is definitely an earlier diagnosis of the disease. Although there are numerous diagnostic methods for AD, their low specificity and high price, often accompanied by a considerable level of patient discomfort, make them unsuitable for early, prodromal screening. In this matter a promising method may be provided using an olfactory test, which is an inexpensive and non-invasive method and thus suitable for screening, although as a test of low specificity, it should be combined with other methods. Introducing new methods of AD treatment does not mean abandoning the traditional ones, based on enhancing cholinergic transmission. They are valuable as long as the therapy starts when abundant brain inclusions disturb the transmissions.
Authors and Affiliations
Eugenia Tęgowska, Adrianna Wosińska
Keywords
Related Articles
- EP ID EP66435
- DOI -
- Views 155
- Downloads 0
Mutacje w genie PKD1 - wpływ na obraz kliniczny pacjentów ze zwyrodnieniem wielotorbielowatym nerek z Dolnego Śląska
Wprowadzenie: Autosomalna, dominująca postać zwyrodnienia torbielowatego nerek (ADPKD) jest jedną z najczęstszych schorzeń genetycznych, charakteryzująca się rozwojem niezliczonej liczby, różnej wielkości torbieli w korz...
Obecność przeciwciał anty-HEV IgG u 182 polskich pacjentów
Activity of N-acetyl-β-hexosaminidase and its isoenzymes A and B in cancer
There were approximately 93,060 deaths from cancers in Poland in 2008, and about 105,000 are predicted for the year 2025. Early detection of cancer is a major problem throughout the world, which is why many researchers a...
Congenital myopathies – skeletal muscle diseases related to disorder of actin filament structure and functions
Congenital myopathies are clinically and genetically heterogeneous disorders characterized by muscle structural abnormalities, muscle weakness and deformities. The clinical spectrum of the disease ranges from severe ca...
ApoE-containing HDL and the development of atherosclerosis
The current state of knowledge about the role of high density lipoproteins (HDL) indicates that their anti-atherogenic function is mainly related to the effectiveness of their actions (mostly to the participation in reve...